Last week, the city council of Hazel Park, Michigan, moved to decriminalize psychedelic substances, including ibogaine and psilocybin. Before the city council unanimously passed the measure, the measure’s sponsor, Councilmember Luke Londo, revealed that he’d personally used psilocybin to manage anxiety and depression.
The resolution talks about the therapeutic potential of psychedelic substances for conditions such as end-of-life anxiety, depression, cluster headaches and post-traumatic stress disorder.
Hazel Park completes the trio of cities in the state of Michigan to enact psychedelic reform, following the cities of Detroit and Ann Arbor. After they decriminalized entheogenic fungi and plants, local legislators in the city of Ann Arbor made the month of September Entheogenic Plants and Fungi Awareness month. The city of Grand Rapids also passed a measure supporting the decriminalization of various psychedelics in 2021. However, the resolution didn’t meet many activists’ expectations given that it wouldn’t actually change any enforcement practices in the city.
The resolution approved in Hazel Park made the investigation and arrest of individuals for engaging in practices with or growing, purchasing, transporting, distributing and possessing entheogenic plants included in Schedule I of the Controlled Substances Act the lowest priority for law enforcement in the city. It also noted that city resources or funds wouldn’t be used in any detection, arrest, prosecution or investigation regarding the use of these plants and plant compounds.
While it did decriminalize psychedelics, the legislation doesn’t authorize driving while under the influence of substances such as ibogaine, ayahuasca and psilocybin; the possession and/or consumption of these substances by minors or in schools; and the commercial sale of these substances.
This move comes as Decriminalize Nature Michigan activists work to place a resolution on the statewide ballot that would establish a system for the spiritual and therapeutic use of psychedelics as well as legalize their possession, cultivation and sharing. This ballot measure would legalize various entheogenic substances for individuals aged 18 and above, including DMT, peyote, mescaline, ibogaine, psilocin and psilocybin. In addition to this, it would authorize certain entities to sell and grow psychedelics for individuals who have written recommendations from their doctors to use the drugs.
The legislation would also amend the current drug statutes in the state and reduce criminal penalties for the possession of any controlled substance under Schedule I or II.
Psychedelics reform is also being pursued in other states across the country, with Utah’s governor signing a legislation that would establish a task force to conduct research on the therapeutic potential of psychedelics and make recommendations on their lawful use.
These changes are coming as many companies, including, Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), are making headway in developing next-generation medicines from psychedelic substances.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.